News - Return on capital employed
2012-05-29 02:26:40
--Revenues Rise 46% Year-Over-Year with Substantial Increases in All Lines of Tissue Business-- --Reducer(TM) COSIRA Trial Advances and Neovasc Tiara(TM)
2012-05-22 10:25:01
RICHMOND, Va., May 22, 2012 /PRNewswire/ -- HIGHLIGHTS Fiscal Year 2012 Diluted earnings per share of $3.25 after $1.42 in net unusual charges.Segment
